Background: A number of guidelines have been developed to improve standardization of the terminology and criteria for cytologic specimens obtained from the thyroid, pancreas, lung, and salivary glands. A major goal of these guidelines is to improve reproducibility and understanding of the reporting of diagnostic results among cytopathologists and between cytopathologists and clinicians. The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology (IAC YSRB) is the most recent of these guidelines. The value of this system is, in part, dependent upon interobserver reproducibility. Design: Ninety consecutive fine-needle aspiration biopsies (FNAB) of the breast, performed over a 6-year period, were independently evaluated by 4 board-certified pathologists blinded to the original diagnoses. The 5 diagnostic categories used were those of the IAC YSRB according to published criteria for these categories. Observed agreement and chance corrected agreement (Fliess κ) were calculated. Differences in κ values were evaluated using the T statistic of Gwent. Statistical calculations were performed using STATA v16.0 (STATA Corp., College Station, TX, USA). Results: Overall agreement between observers was good. Observed unweighted agreement was 69% and weighted agreement was 91%. The majority of diagnoses were concordant (68.6%). Conclusions: Interobserver agreement of 4 cytopathologists was good using the 5 categories of the IAC YRSB (69%). Agreement was greater among pathologists with more years of experience. The IAC YSRB system appears to provide greater agreement among viewers than guidelines for cytologic specimens obtained from some other body sites (salivary gland and lung). Most discrepancies were only by a single category, with only 22/113 (19%) differing by more than one category.

1.
Pitman
MB
,
Layfield
LJ
.
The Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology
.
Cham, Switzerland
:
Springer Nature AG
;
2015
. pp.
1
3
.
2.
Nayar
R
,
Vielh
P
. From Bethesda to Paris – At Last We Have Standardized Terminology for Urinary Cytology. In:
Rosenthal
DL
,
Wojcik
EM
,
Kurtycz
DF
, editors
.
The Paris System for Reporting Urinary Cytology
.
Cham, Switzerland
:
Springer Nature AG
;
2016
. pp.
vii
vii
.
3.
Baloch
ZW
,
Cooper
DS
,
Gharib
H
,
Alexander
EK
. Overview of Diagnostic Terminology and Reporting. In:
Ali
SZ
, editor
.
Cibas (ES)
:
The Bethesda System for Reporting Thyroid Cytopathology. Cham Switzerland. Springer Nature Switzerland AG
;
2018
. pp.
1
6
.
4.
Baloch
Z
,
Field
AS
,
Katabi
N
,
Wenig
BM
. The Milan System for reporting Salivary Gland Cytopathology. In:
Baloch
Z
,
Barkan
FA
,
Foschini
MP
,
Kurtycz
DF
,
Pusztaszeri
M
,
Vielh
P
, editors
.
The Milan System for Reporting Salivary Gland Cytopathology
.
Cham, Switzerland
:
Springer Nature Switzerland AG
;
2018
. pp.
1
9
.
5.
Jalay
JB
,
Ioannidis
I
,
Layfield
LJ
,
Baloch
Z
. Overview of Diagnostic Terminology and Reporting. In:
Layfield
LJ
,
Baloch
Z
, editors
.
The Papanicolaou Society of Cytopathology System for Reporting Respiratory Cytology
.
Cham, Switzerland
:
Springer Nature Switzerland AG
;
2019
. pp.
1
6
.
6.
Field
AS
,
Raymond
WA
,
Rickard
M
,
Arnold
L
,
Brachtel
EF
,
Chaiwun
B
, et al;
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology
.
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology
.
Acta Cytol
.
2019
;
63
(
4
Suppl. 4
):
257
73
.
[PubMed]
0001-5547
7.
Wong
S
,
Rickard
M
,
Earls
P
,
Arnold
L
,
Bako
B
,
Field
AS
.
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology: A single institutional retrospective study of the application of the system categories and the impact of rapid onsite evaluation
.
Acta Cytol
.
2019
;
63
(
4
Suppl. 4
):
280
91
.
[PubMed]
0001-5547
8.
Montezuma
D
,
Malheiros
D
,
Schmitt
FC
.
Malheiros, Schmitt FC. Breast fine-needle aspiration biopsy cytology using the newly proposed IAC Yokohama System for Reporting Breast Cytopathology: the experience of a single institution
.
Acta Cytol
.
2019
;
63
Suppl. 4
:
274
9
. 0001-5547
9.
Layfield
LJ
,
Glasgow
BJ
,
Cramer
H
. Fine-needle aspiration in the management of breast masses.
Pathology Annual: Nineteen Eighty-Nine. Part 2 Rosen PP, Fechner RE
.
Norwalk (Conn.)
:
Appleton and Lange
;
1989
. pp.
23
62
.
10.
Barrows
GH
,
Anderson
TJ
,
Lamb
JL
,
Dixon
JM
.
Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies
.
Cancer
.
1986
Oct
;
58
(
7
):
1493
8
.
[PubMed]
0008-543X
11.
Dixon
JM
,
Lamb
J
,
Anderson
TJ
.
Fine needle aspiration of the breast: importance of the operator
.
Lancet
.
1983
Sep
;
2
(
8349
):
564
.
[PubMed]
0140-6736
12.
Lee
KR
,
Foster
RS
,
Papillo
JL
.
Fine needle aspiration of the breast. Importance of the aspirator
.
Acta Cytol
.
1987
May-Jun
;
31
(
3
):
281
4
.
[PubMed]
0001-5547
13.
Layfield
LJ
,
Esebua
M
,
Yang
Z
,
Vatzmitsel
M
,
Giorgadze
T
,
Schmidt
R
.
The Milan system for reporting salivary gland cytopathology: A study of inter-observer reproducibility
.
Diagn Cytopathol
.
2019
Aug
;
47
(
8
):
765
8
.
[PubMed]
8755-1039
14.
Layfield
LJ
,
Esebua
M
,
Dodd
L
,
Giorgadze
T
,
Schmidt
RL
. The Papanicolaou Society of Cytopathology guidelines for respiratory cytology: Reproducibility of categories among observers. Cytojournal
2018
; 15, 22. doi: . 4_18. eCollection 2018.
15.
Long
T
,
Layfield
LJ
,
Esebua
M
,
Frazier
SR
,
Giorgadze
DT
,
Schmidt
RL
.
Inter-observer reproducibility of The Paris System for Reporting Urinary Cytology.
Cytojournal
2017
; 24:14;17. doi: . eCollection 2017.
16.
Hoda
RS
,
Brachtel
EF
.
International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology: A Review of Predictive Values and Risks of Malignancy
.
Acta Cytol
.
2019
;
63
(
4
Suppl. 4
):
292
301
.
[PubMed]
0001-5547
17.
Fleiss
JL
.
Measuring nominal scale agreement among many raters
.
Psychol Bull
.
1971
;
76
(
5
):
378
82
. 0033-2909
18.
Gwet
KL
.
Testing the differences of correlated agreement coefficients for statistical significance
.
Educ Psychol Meas
.
2016
Aug
;
76
(
4
):
609
37
.
[PubMed]
0013-1644
19.
Layfield
LJ
,
Schmidt
RL
,
Chadwick
BE
,
Esebua
M
,
Witt
BL
.
Interobserver reproducibility and agreement with original diagnosis in the categories “atypical” and “suspicious for malignancy” for bile and pancreatic duct brushings
.
Diagn Cytopathol
.
2015
Oct
;
43
(
10
):
797
801
.
[PubMed]
8755-1039
20.
Abati
A
,
Abele
J
,
Bacus
SS
, et al
The uniform approach to breast fine needle aspiration biopsy. A synopsis
.
Acta Cytol
.
1996
Nov-Dec
;
40
(
6
):
1120
6
.
[PubMed]
0001-5547
21.
Abati
A
,
Abele
J
,
Bacus
SS
, et al;
National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees
.
The uniform approach to breast fine-needle aspiration biopsy
.
Diagn Cytopathol
.
1997
Apr
;
16
(
4
):
295
311
.
[PubMed]
8755-1039
22.
Abati
A
,
Simsir
A
.
Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices
.
Clin Lab Med
.
2005
Dec
;
25
(
4
):
631
54
.
[PubMed]
0272-2712
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.